Regulating animals with gene drive systems: lessons from the regulatory assessment of a genetically engineered mosquito

References

• Barben, D., E. Fisher, C. Selin, and D. H. Guston. 2008. “Anticipatory Governance of Nanotechnology: Foresight, Engagement, and Integration.” In The Handbook of Science and Technology Studies, edited by E. Hackett, O. Amsterdamska, M. Lynch, and J. Wajcman, 979–1000. Cambridge: MIT Press.
   Google Scholar
• Barley, S. R. 2007. “Corporations, Democracy, and the Public Good.” Journal of Management Inquiry 16 (3): 201–215. doi: 10.1177/1056492607305891
   Web of Science ®Google Scholar
• Boëte, C., and R. G. Reeves. 2016. “Alternative Vector Control Methods to Manage the Zika Virus Outbreak: More Haste, Less Speed.” The Lancet Global Health 4 (6): e363. doi: 10.1016/S2214-109X(16)00084-X
   PubMed Web of Science ®Google Scholar
• Burt, A. 2003. “Site-Specific Selfish Genes as Tools for the Control and Genetic Engineering of Natural Populations.” Proceedings of the Royal Society of London B: Biological Sciences 270 (1518): 921–928. doi: 10.1098/rspb.2002.2319
   PubMed Web of Science ®Google Scholar
• Carvalho, D. O., A. R. McKemey, L. Garziera, R. Lacroix, C. A. Donnelly, L. Alphey, A. Malavasi, and M. L. Capurro. 2015. “Suppression of a Field Population of Aedes aegypti in Brazil by Sustained Release of Transgenic Male Mosquitoes.” Plos Neglected Tropical Diseases 9 (7): e0003864. doi: 10.1371/journal.pntd.0003864
   PubMed Web of Science ®Google Scholar
• Cowan, T., and K. Alexander. 2012. Deregulating Genetically Engineered Alfalfa and Sugar Beets: Legal and Administrative Responses. Washington, DC: Congressional Research Service.
   Google Scholar
• Daghrir, R., and P. Drogui. 2013. “Tetracycline Antibiotics in the Environment: A Review.” Environmental Chemistry Letters 11 (3): 209–227. doi: 10.1007/s10311-013-0404-8
   Web of Science ®Google Scholar
• Esvelt, K. M., A. L. Smidler, F. Catteruccia, and G. M. Church. 2014. “Concerning RNA-guided Gene Drives for the Alteration of Wild Populations.” Elife 3: 20131071. doi: 10.7554/eLife.03401
   Web of Science ®Google Scholar
• FDA. 1992. “Statement of Policy: Foods Derived from New Plant Varieties.” Federal Register 57: 22984–23005.
   Google Scholar
• FDA. 2017. “Clarification of FDA and EPA Jurisdiction over Mosquito-related Products.” Revised October 2017. https://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM533600.pdf.
   Google Scholar
• FDA-CVM. 2008. “FDA’s Response to Public Comments on Draft Guidance for Industry #187.” September 19. https://www.fda.gov/animalveterinary/developmentapprovalprocess/geneticengineering/geneticallyengineeredanimals/ucm113612.htm.
   Google Scholar
• FDA-CVM. 2009. “Guidance for Industry Regulation of Intentionally Altered Genomic DNA in Animals #187.”  Revised 2015 & 2017. https://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm113903.pdf.
   Google Scholar
• FDA-CVM. 2016. “Preliminary Finding of No Significant Impact in Support of an Investigational Field Trial of OX513A Aedes aegypti Mosquitoes.” http://www.fda.gov/downloads/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/UCM487379.pdf.
   Google Scholar
• Federal Register. 1981. “Executive Order 12291 – Federal Regulation.” Federal Register 46: 13193.
   Google Scholar
• Federal Register. 1984. “Biotechnology Regulation, Coordinated Framework; Inquiry.” Federal Register 49: 50856.
   PubMedGoogle Scholar
• Gantz, V. M., N. Jasinskiene, O. Tatarenkova, A. Fazekas, V. M. Macias, E. Bier, and A. A. James. 2015. “Highly Efficient Cas9-Mediated Gene Drive for Population Modification of the Malaria Vector Mosquito Anopheles stephensi.” Proceedings of the National Academy of Sciences 112 (49): E6736–E6743. doi: 10.1073/pnas.1521077112
   PubMed Web of Science ®Google Scholar
• Gloria-Soria, A., J. E. Brown, V. Kramer, M. Hardstone Yoshimizu, and J. R. Powell. 2014. “Origin of the Dengue Fever Mosquito Aedes aegypti, in California.” PLoS NTD 8 (7): e3029.
   Google Scholar
• Hammond, A., R. Galizi, K. Kyrou, A. Simoni, C. Siniscalchi, D. Katsanos, M. Gribble, et al. 2016. “A CRISPR-Cas9 Gene Drive System Targeting Female Reproduction in the Malaria Mosquito Vector Anopheles gambiae.” Nature Biotechnology 34 (1): 78–83. doi: 10.1038/nbt.3439
   PubMed Web of Science ®Google Scholar
• Harris, A. F., A. R. McKemey, D. Nimmo, Z. Curtis, I. Black, S. A. Morgan, M. N. Oviedo, et al. 2012. “Successful Suppression of a Field Mosquito Population by Sustained Release of Engineered Male Mosquitoes.” Nature Biotechnology 30 (9): 828–830. doi: 10.1038/nbt.2350
   PubMed Web of Science ®Google Scholar
• Harris, A. F., D. Nimmo, A. R. McKemey, N. Kelly, S. Scaife, C. A. Donnelly, C. Beech, W. D. Petrie, and L. Alphey. 2011. “Field Performance of Engineered Male Mosquitoes.” Nature Biotechnology 29 (11): 1034–1037. doi: 10.1038/nbt.2019
   PubMed Web of Science ®Google Scholar
• Harvey, D. 2005. A Brief History of Neoliberalism. Cambridge: Oxford University Press.
   Google Scholar
• Hilts, P.J. 2003. Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation. New York: Alfred A. Knopf.
   Google Scholar
• Jasanoff, S. 2005. Designs on Nature: Science and Democracy in Europe and the United States. Princeton, NJ: Princeton University Press.
   Google Scholar
• Keat et al. v. U.S. DHHS FDA. 2016. “Case 3:16-cv-01574 Document 1 Filed 03/30/16.” http://www.centerforfoodsafety.org/files/2016-3-30-dkt-1--pls--complaint_94703.pdf.
   Google Scholar
• Keyworth, G. 1981. “Testimony. US Congress, House of Representatives, Committee on Science and Technology.” https://www.gpo.gov/fdsys/pkg/GPO-CRECB-1982-pt8/pdf/GPO-CRECB-1982-pt8-5-1.pdf
   Google Scholar
• Kuzma, J. 2016. “A Missed Opportunity for US Biotechnology Regulation.” Science 353 (6305): 1211–1213.
   PubMed Web of Science ®Google Scholar
• Kuzma, J., and J. C. Besley. 2008. “Ethics of Risk Analysis and Regulatory Review: From Bio-To Nanotechnology.” Nanoethics 2 (2): 149–162. doi: 10.1007/s11569-008-0035-x
   Google Scholar
• Kuzma, J., F. Gould, Z. S. Brown, J. P. Collins, J. A. Delborne, E. Frow, K. Esvelt, et al. 2017. “A Roadmap for Gene Drives: Using Institutional Analysis and Development to Frame Research Needs and Governance in a Systems Context.” Journal of Responsible Innovation 5 (S1): S13–S39. doi:10.1080/23299460.2017.1410344.
   Google Scholar
• Levidow, L., J. Murphy, and S. Carr. 2007. “Recasting ‘Substantial Equivalence’: Transatlantic Governance of GM Food.” Science, Technology, & Human Values 32 (1): 26–64. doi: 10.1177/0162243906293885
   Web of Science ®Google Scholar
• Markel, H. 2005. “Why America Needs a Strong FDA.” Journal of the American Medical Association 294: 2489–2491. doi: 10.1001/jama.294.19.2489
   Web of Science ®Google Scholar
• Meghani, Z. 2014. “Risk Assessment of Genetically Modified Food and Neoliberalism: An Argument for Democratizing the Regulatory Review Protocol of the Food and Drug Administration.” Journal of Agricultural and Environmental Ethics 27 (6): 967–989. doi: 10.1007/s10806-014-9511-1
   Web of Science ®Google Scholar
• Meghani, Z. 2017a. “Regulations of Consumer Products.” In Consumer Perception of Product Risks and Benefits, edited by G. Emilien, R. Weitkunat, and F. Luedicke, 495–513. Dordrecht: Springer.
   Google Scholar
• Meghani, Z. 2017b. “Genetically Engineered Animals, Drugs, and Neoliberalism: The Need for a New Biotechnology Regulatory Policy Framework.” Journal of Agricultural and Environmental Ethics. Advance online publication. doi:10.1007/s10806-017-9696-1.
   PubMed Web of Science ®Google Scholar
• Meghani, Z., and J. Kuzma. 2011. “The ‘Revolving Door’ Between Regulatory Agencies and Industry: A Problem That Requires Reconceptualizing Objectivity.” Journal of Agricultural And Environmental Ethics 24 (6): 575–599. doi: 10.1007/s10806-010-9287-x
   Web of Science ®Google Scholar
• Meghani, Z., and I. Melo-Martín. 2009. “The US Food and Drug Administration’s Evaluation of the Safety of Animal Clones: A Failure to Recognize the Normativity of Risk Assessment Projects.” Bulletin of Science, Technology & Society 29 (1): 9–17. doi: 10.1177/0270467608329950
   Google Scholar
• Murphy, B., C. Jansen, J. Murray, and P. De Barro. 2010. Risk Analysis on the Australian Release of Aedes aegypti (L.)(Diptera: Culicidae) Containing Wolbachia. Canberra: CSIRO. http://www.eliminatedengue.com/library/publication/document/csiro_report_australia_2010.pdf.
   Google Scholar
• NASEM. 2016. Gene Drives on the Horizon: Advancing Science, Navigating Uncertainty, and Aligning Research with Public Values. Washington, DC: National Academies Press.
   Google Scholar
• NASEM. 2017. Preparing for Future Products of Biotechnology. Washington, DC: National Academies Press.
   Google Scholar
• Nimmo, D. D., and C. Beech. 2016. “Genetically Engineered Mosquitoes in the US.” Outlooks on Pest Management 26 (5): 207–210. doi: 10.1564/v26_oct_05
   Google Scholar
• NRC. 1996. Understanding Risk: Informing Decisions in a Democratic Society. Washington, DC: National Academies Press.
   Google Scholar
• Otts, S. S. 2014. “US Regulatory Framework for Genetic Biocontrol of Invasive Fish.” Biological Invasions 16 (6): 1289–1298. doi: 10.1007/s10530-012-0327-5
   Web of Science ®Google Scholar
• Oxitec. 2016. “Draft Environmental Assessment for Investigational Use of Aedes aegypti OX513A.” http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/ucm446529.htm.
   Google Scholar
• Oye, K. A., K. Esvelt, E. Appleton, F. Catteruccia, G. Church, T. Kuiken, S. Bar-Yam Lightfoot, J. McNamara, A. Smidler, and J. P. Collins. 2014. “Regulating Gene Drives.” Science 345: 626–628. doi: 10.1126/science.1254287
   PubMed Web of Science ®Google Scholar
• Parthasarathy, S. 2012. Building Genetic Medicine. Cambridge: MIT Press.
   Google Scholar
• Reagan, R. 1982. “Message to the Congress Transmitting the Annual Economic Report of the President.” http://www.reagan.utexas.edu/archives/speeches/1982/21082a.htm.
   Google Scholar
• Reeves, R. G., J. A. Denton, F. Santucci, J. Bryk, and F. A. Reed. 2012. “Scientific Standards and the Regulation of Genetically Modified Insects.” PLoS Neglected Tropical Diseases 6 (1): e1502. doi: 10.1371/journal.pntd.0001502
   PubMed Web of Science ®Google Scholar
• Thompson, P. B. 1997. “Science Policy and Moral Purity: The Case of Animal Biotechnology.” Agriculture and Human Values 14 (1): 11–27. doi: 10.1023/A:1007397315714
   Google Scholar
• Unlu, M. 2009. “It Is Time: Why the FDA Should Start Disclosing Drug Trial Data.” Michigan Telecommunications and Technology Law Review 16: 511.
   Google Scholar
• USDA. 2017. “Petitions for Determination of Nonregulated Status.” https://www.aphis.usda.gov/aphis/ourfocus/biotechnology/permits-notifications-petitions/petitions/petition-status.
   Google Scholar
• White House. [2015] 2016. “Modernizing the Regulatory System for Biotechnology Products: An Update to the Coordinated Framework for the Regulation of Biotechnology.” https://www.epa.gov/regulation-biotechnology-under-tsca-and-fifra/modernizing-regulatory-system-biotechnology-products.
   Google Scholar
• Wickson, F. 2007. “From Risk to Uncertainty in the Regulation of GMOs: Social Theory and Australian Practice.” New Genetics and Society 26 (3): 325–339. doi: 10.1080/14636770701701832
   Web of Science ®Google Scholar